New Directions, New Hope
Wednesday, January 21, 2015
Join FARE's new Chief Executive Officer, James R. Baker, Jr., M.D., as he gives FARE's annual food allergy research update.
Prior to serving as interim CEO and interim chief medical officer, Baker was a member of FARE’s Research Advisory Board, helping set the research strategy for the organization and reviewing research proposals. A board-certified allergist and accomplished researcher with more than three decades in the field, Baker has been instrumental in the development and execution of “A Vision and Plan for Food Allergy Research,” FARE’s ambitious strategic plan for advancing the field of food allergy research published in 2013. Baker also has been a strong advocate for improving food allergy education, promoting food allergy advocacy initiatives and increasing awareness of the potentially life-threatening nature of food allergies.
Baker recently served as senior vice president and global vaccine head at Merck Corporation. Previous to that he directed the Nanotechnology Institute at the University of Michigan and was CEO of NanoBio Corporation. For over 20 years he was the Ruth Dow Doan Professor and chief of the Division of Allergy and Clinical Immunology at the University of Michigan, where he started the Food Allergy Research Center. He retains his professorship and serves in an emeritus capacity at the university.